Sign In
Buy GHSI
$3.22
+0 (+0%)
At Close: Sep 18, 2025
Guardion Health Sciences Announces Declaration of Cash Distribution
03:55pm, Monday, 23'rd Dec 2024
HOUSTON, TEXAS, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) today announced that its Board of Directors declared a cash distribution (the “
Guardion Health Sciences Announces Filing of Certificate of Dissolution
05:37pm, Wednesday, 30'th Oct 2024
HOUSTON, TEXAS, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”) today announced that it has filed a certificate of dissolution wit
Guardion Health Sciences Declares Cash Dividend of $5.00 Per Share of Common Stock
04:05pm, Wednesday, 21'st Aug 2024
HOUSTON, TEXAS, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”) today announced that its Board of Directors declared a cash divide
Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2024
04:35pm, Tuesday, 13'th Aug 2024
Guardion Also Provides an Update to Stockholders of Significant Recent Developments HOUSTON, TEXAS, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or t
HOUSTON, TEXAS, May 31, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-ba
Guardion Health Sciences Announces Approval by Stockholders of Proposed Sale of Viactiv Business
03:00pm, Thursday, 23'rd May 2024
Adjourns Special Meeting to May 31, 2024 in order to Solicit Additional Proxies in Support of its Plan of Liquidation and Dissolution
Guardion Health Sciences Announces
05:01pm, Monday, 13'th May 2024
-- Financial Results for the Three Months Ended March 31, 2024 -- Institutional Shareholder Services Issues Report Recommending that Institutional Stockholders Vote in Favor of All Proposals at the Up
Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023
06:15am, Friday, 29'th Mar 2024
Viactiv ® Product Line Generated Net Revenues of Approximately $11.9 Million for the Year Ended December 31, 2023, an Increase of Approximately 12% as Compared to the Year Ended December 31, 2022
Why Is Guardion Health (GHSI) Stock Up 66% Today?
10:54am, Wednesday, 31'st Jan 2024
Guardion Health Sciences (NASDAQ: GHSI ) stock is rocketing higher on Wednesday after the company announced an agreement to sell its Activ Nutritional subsidiary. Doctor's Best is acting as the buyer
What made Guardion Health stock double on Wednesday?
08:47am, Wednesday, 31'st Jan 2024
Guardion Health Sciences Inc (NASDAQ: GHSI) is up nearly 100% this morning after Doctor's Best Inc agreed to buy its Activ Nutritional LLC. Could Guardion Health stock climb any further?
HOUSTON, TEXAS, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”) announced today that it has signed an equity purchase agreement to
Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2023
04:10pm, Monday, 13'th Nov 2023
Viactiv ® Generated Net Revenues of Approximately $3.3 Million for the Three Months Ended September 30, 2023, an increase of 27% over the Three Months Ended September 30, 2022
Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2023
08:15am, Monday, 14'th Aug 2023
Viactiv® Product Line Total Revenue Increased Approximately 6% for the Six Months Ended June 30, 2023, as Compared to the Six Months Ended June 30, 2022; Robust Growth in Amazon Sales Channel Demonst
Guardion Health Sciences, Inc. Regains Compliance With Nasdaq Continued Listing Requirements
09:05pm, Tuesday, 24'th Jan 2023 GlobeNewswire Inc.
HOUSTON, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc (“Guardion” or the “Company”) (NASDAQ: GHSI) announced today that it has received confirmation from The Nasdaq Stock
Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
06:42pm, Monday, 09'th Jan 2023 Benzinga
Gainers
CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash.
Apexigen, Inc. (NASDAQ: APGN) jumped 111% to
